Inspire Medical Systems, Inc. Sustainability Profile
Inspire Medical Systems, Inc., a pioneering entity in the medical technology industry, is headquartered in the United States. Founded in 2007, the company has made significant strides in the treatment of obstructive sleep apnoea (OSA) through its innovative Inspire therapy. This unique, implantable device offers a groundbreaking alternative to traditional CPAP machines, providing patients with a more comfortable and effective solution for managing their condition. With a focus on enhancing patient quality of life, Inspire Medical Systems has established a strong market position, recognised for its commitment to advancing sleep health. The company operates primarily in North America and has garnered notable achievements, including FDA approval for its flagship product. By combining cutting-edge technology with a patient-centric approach, Inspire Medical Systems continues to lead the way in transforming sleep disorder treatment.
DitchCarbon Score
How does Inspire Medical Systems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Inspire Medical Systems, Inc.'s score of 31 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Inspire Medical Systems, Inc.'s reported carbon emissions
In 2023, Inspire Medical Systems, Inc. reported total carbon emissions of approximately 56,219,020 kg CO2e. This figure includes Scope 1 emissions of about 50,630 kg CO2e, Scope 2 emissions of approximately 401,740 kg CO2e, and a significant contribution from Scope 3 emissions, which total around 55,766,650 kg CO2e. The Scope 3 emissions breakdown reveals major sources, including purchased goods and services (approximately 41,471,850 kg CO2e) and business travel (about 6,602,150 kg CO2e). Inspire Medical Systems is actively pursuing climate commitments, having initiated a formal climate risk assessment and scenario analysis in early 2025. This assessment aims to enhance understanding of both physical and transition climate risks, with the results expected to inform future management strategies. The company has set near-term net-zero reduction targets for both Scope 1 and Scope 2 emissions, with a completion timeframe extending to late 2025. As of now, there are no specific reduction percentages disclosed for these targets. The emissions data is not cascaded from any parent organization, indicating that all reported figures are directly from Inspire Medical Systems, Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 50,630 |
| Scope 2 | 401,740 |
| Scope 3 | 55,766,650 |
How Carbon Intensive is Inspire Medical Systems, Inc.'s Industry?
How Carbon Intensive is Inspire Medical Systems, Inc.'s Location?
Inspire Medical Systems, Inc.'s Scope 3 Categories Breakdown
Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 74% of Scope 3 emissions.
Top Scope 3 Categories
Inspire Medical Systems, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Inspire Medical Systems, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
